Clene Inc. financial data

Symbol
CLNN, CLNNW on Nasdaq
Industry
Pharmaceutical Preparations
Location
6550 South Millrock Drive, Suite G50, Salt Lake City, Utah
Fiscal year end
December 31
Former names
Chelsea Worldwide Inc. (to 12/18/2020)
Latest financial report
10-Q - Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 236 % -2.05%
Quick Ratio 0.32 % -48.4%
Debt-to-equity 272 %
Return On Equity -322 % -124%
Return On Assets -86.5 % -25.9%
Operating Margin -6.3 K % +24.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 128 M shares +66.9%
Common Stock, Shares, Outstanding 128 M shares +64.7%
Entity Public Float 78.1 M USD -8.44%
Common Stock, Value, Issued 13 K USD +62.5%
Weighted Average Number of Shares Outstanding, Basic 128 M shares +68.9%
Weighted Average Number of Shares Outstanding, Diluted 63.5 M shares -9.32%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 620 K USD +12.7%
Cost of Revenue 132 K USD +326%
Research and Development Expense 25.1 M USD -18.2%
General and Administrative Expense 14.4 M USD -7.63%
Costs and Expenses 39.7 M USD -14.4%
Operating Income (Loss) -39 M USD +14.8%
Nonoperating Income (Expense) -9.77 M USD -156%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -48.8 M USD -72.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -48.8 M USD -72.3%
Earnings Per Share, Basic -0.41 USD/shares -2.5%
Earnings Per Share, Diluted -0.17 USD/shares -140%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 21.7 M USD +17.8%
Marketable Securities, Current 6.18 M USD
Cash, Cash Equivalents, and Short-term Investments 27.9 M USD +51.6%
Accounts Receivable, after Allowance for Credit Loss, Current 64 K USD +1.59%
Inventory, Net 37 K USD -58%
Other Assets, Current 832 K USD -13.5%
Assets, Current 32.1 M USD +29.4%
Property, Plant and Equipment, Net 9.75 M USD +130%
Operating Lease, Right-of-Use Asset 4.05 M USD -9.97%
Assets 45.1 M USD +13%
Accounts Payable, Current 1.65 M USD +171%
Accrued Liabilities, Current 3.91 M USD -34.2%
Liabilities, Current 26.2 M USD +55.2%
Operating Lease, Liability, Noncurrent 4.72 M USD -12.6%
Liabilities 40.8 M USD -1.71%
Accumulated Other Comprehensive Income (Loss), Net of Tax 140 K USD -36.7%
Retained Earnings (Accumulated Deficit) -254 M USD -23.8%
Stockholders' Equity Attributable to Parent 4.26 M USD
Liabilities and Equity 45.1 M USD +13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.08 M USD +23.2%
Net Cash Provided by (Used in) Financing Activities -19 K USD -100%
Net Cash Provided by (Used in) Investing Activities 71 K USD -98.5%
Common Stock, Shares Authorized 300 M shares +100%
Common Stock, Shares, Issued 128 M shares +64.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.09 M USD -6545%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 21.8 M USD +17.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 784 K USD -20.2%
Deferred Tax Assets, Valuation Allowance 57.3 M USD +28.3%
Operating Lease, Liability 5.32 M USD -9.95%
Depreciation 1.72 M USD +40.5%
Payments to Acquire Property, Plant, and Equipment 11 K USD -96%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -48.9 M USD -72.5%
Lessee, Operating Lease, Liability, to be Paid 7.15 M USD -13.7%
Property, Plant and Equipment, Gross 14.7 M USD +76.6%
Operating Lease, Liability, Current 599 K USD +17.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.24 M USD +2.83%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.21 M USD +3.16%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.83 M USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.13 M USD -8.04%
Deferred Tax Assets, Operating Loss Carryforwards 35.2 M USD +15.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.09 M USD -3.19%
Operating Lease, Payments 307 K USD +1.32%
Additional Paid in Capital 258 M USD +27%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 8.91 M USD +4.37%
Interest Expense 4.74 M USD +32.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%